IDDO is working with the global visceral leishmaniasis (VL) research community to collate data and deliver robust science to address knowledge gaps and save lives with better treatment. To date, this collaboration has assembled a harmonised clinical trials database containing over 14,000 individual patient data (IPD), representing nearly half of the published sample size from the last 15 years.
News